A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered GB1211 in Participants With Suspected or Confirmed Non-alcoholic Steatohepatitis (NASH) and Liver Fibrosis

Condition:   Non-alcoholic Steatohepatitis (NASH) Interventions:   Drug: GB1211;   Drug: Placebo Sponsors:   Galecto Biotech AB;   Covance Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials